1.Huang SH, Tsai MS, Lee CY, Tsai CS, Liu CE, Lee YT, Chen HA, Chen LY, Lu YM,

Tsai WC, Hsu WT, Liu WD, Yang CJ, Sun HY, Ko WC, Lu PL, Hung CC; Taiwan HIV

Study Group. Ongoing transmission of Entamoeba histolytica among newly diagnosed

people living with HIV in Taiwan, 2009-2018. PLoS Negl Trop Dis. 2020 Jun

12;14(6):e0008400. doi: 10.1371/journal.pntd.0008400. Epub ahead of print. PMID:

32530918.

 

2.Tsai MS, Zhang JY, Sun HY, Liu WC, Wu PY, Yang CJ, Hung CC. Performance of

fracture risk assessment tool in HIV-positive male individuals aged ≥45 years on

suppressive antiretroviral therapy. J Int AIDS Soc. 2019 Aug;22(8):e25383. doi:

10.1002/jia2.25383. PMID: 31423752; PMCID: PMC6698691.

 

3.Wei YF, Lim CK, Tsai MS, Huang MS, Chen KY. Intracranial Responses to

Afatinib at Different Doses in Patients With EGFR-mutated Non-small-cell Lung

Carcinoma and Brain Metastases. Clin Lung Cancer. 2019 May;20(3):e274-e283. doi:

10.1016/j.cllc.2019.02.009. Epub 2019 Feb 26. PMID: 30930121.

 

4.Lim CK, Wei YF, Tsai MS, Chen KY, Shih JY, Yu CJ. Treatment effectiveness and

tolerability of afatinib at different doses in patients with EGFR-mutated lung

adenocarcinoma: How low can we go? Eur J Cancer. 2018 Nov;103:32-40. doi:

10.1016/j.ejca.2018.07.128. Epub 2018 Sep 8. PMID: 30199768.

 

5.Cheng CY, Tsai MS, Yang CJ, Cheng SH, Sun HY, Chang SF, Su LH, Su YC, Hung

CC, Chang SY. Patterns of emergent resistance-associated mutations after

initiation of non-nucleoside reverse-transcriptase inhibitor-containing

antiretroviral regimens in Taiwan: a multicenter cohort study. Infect Drug

Resist. 2018 Jun 5;11:849-859. doi: 10.2147/IDR.S158341. PMID: 29892199; PMCID:

PMC5993039.

 

6.Li CW, Yang CJ, Sun HY, Tsai MS, Lin SP, Lin TY, Cheng CY, Lee YC, Huang YS,

Liu CE, Lee YT, Tang HJ, Wang NC, Cheng SH, Ko WC, Hung CC; Taiwan HIV Study

Group. Changing seroprevalence of hepatitis C virus infection among HIV-positive

patients in Taiwan. PLoS One. 2018 Mar 16;13(3):e0194149. doi:

10.1371/journal.pone.0194149. PMID: 29547628; PMCID: PMC5856341.

 

7.Lee YL, Lin KY, Cheng CY, Li CW, Yang CJ, Tsai MS, Tang HJ, Lin TY, Wang NC,

Lee YC, Lin SP, Huang YS, Sun HY, Zhang JY, Ko WC, Cheng SH, Lee YT, Liu CE,

Hung CC; Taiwan HIV Study Group. Evolution of hepatitis A virus seroprevalence

among HIV-positive adults in Taiwan. PLoS One. 2017 Oct 16;12(10):e0186338. doi:

10.1371/journal.pone.0186338. PMID: 29036227; PMCID: PMC5643057.

 

8.Lin TY, Yang CJ, Liu CE, Tang HJ, Chen TC, Chen GJ, Hung TC, Lin KY, Cheng

CY, Lee YC, Lin SP, Tsai MS, Lee YL, Cheng SH, Hung CC, Wang NC; Taiwan HIV

Study Group. Clinical features of acute human immunodeficiency virus infection

in Taiwan: A multicenter study. J Microbiol Immunol Infect. 2019

Oct;52(5):700-709. doi: 10.1016/j.jmii.2018.01.005. Epub 2018 Mar 2. PMID:

29555411.

 

9.Lin KY, Cheng CY, Li CW, Yang CJ, Tsai MS, Liu CE, Lee YT, Tang HJ, Wang NC,

Lin TY, Lee YC, Lin SP, Huang YS, Zhang JY, Ko WC, Cheng SH, Hung CC; Taiwan HIV

Study Group. Trends and outcomes of late initiation of combination

antiretroviral therapy driven by late presentation among HIV-positive Taiwanese

patients in the era of treatment scale-up. PLoS One. 2017 Jun 30;12(6):e0179870.

doi: 10.1371/journal.pone.0179870. PMID: 28665938; PMCID: PMC5493332.

 

10.Wu PY, Cheng CY, Liu CE, Lee YC, Yang CJ, Tsai MS, Cheng SH, Lin SP, Lin DY,

Wang NC, Lee YC, Sun HY, Tang HJ, Hung CC. Multicenter study of skin rashes and

hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-

nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase

inhibitors in Taiwan. PLoS One. 2017 Feb 21;12(2):e0171596. doi:

10.1371/journal.pone.0171596. PMID: 28222098; PMCID: PMC5319792.

 

11.Cheng A, Chang SY, Sun HY, Tsai MS, Liu WC, Su YC, Wu PY, Hung CC, Chang SC.

Long-term Durability of Responses to 2 or 3 Doses of Hepatitis A Vaccination in

Human Immunodeficiency Virus-Positive Adults on Antiretroviral Therapy. J Infect

Dis. 2017 Feb 15;215(4):606-613. doi: 10.1093/infdis/jiw605. PMID: 28011921.

 

12.Cheng A, Sun HY, Tsai MS, Ko WJ, Tsai PR, Hu FC, Chen YC, Chang SC.

Predictors of survival in adults undergoing extracorporeal membrane oxygenation

with severe infections. J Thorac Cardiovasc Surg. 2016 Dec;152(6):1526-1536.e1.

doi: 10.1016/j.jtcvs.2016.08.038. Epub 2016 Aug 30. PMID: 27692951.

 

13.Lee YC, Hung CC, Tsai MS, Zhang JY, Wu PY, Yang SP, Luo YZ, Chang HY, Liu

WC, Sun HY, Chang SC. Incidence and risk factors of herpes zoster in human

immunodeficiency virus-positive patients initiating combination antiretroviral

therapy in Taiwan. J Microbiol Immunol Infect. 2018 Feb;51(1):38-44. doi:

10.1016/j.jmii.2016.04.011. Epub 2016 May 13. PMID: 27329131.

 

14.Tsai MS, Chang SY, Lin SW, Kuo CH, Sun HY, Wu BR, Tang SY, Liu WC, Su YC,

Hung CC, Chang SC. Treatment response to unboosted atazanavir in combination

with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency

virus-1-infected patients who have achieved virological suppression: A

therapeutic drug monitoring and pharmacogenetic study. J Microbiol Immunol

Infect. 2017 Dec;50(6):789-797. doi: 10.1016/j.jmii.2015.12.012. Epub 2016 Jan

11. PMID: 26857335.

 

15.Cheng A, Chang SY, Tsai MS, Su YC, Liu WC, Sun HY, Hung CC. Long-term immune

responses and comparative effectiveness of one or two doses of 7-valent

pneumococcal conjugate vaccine (PCV7) in HIV-positive adults in the era of

combination antiretroviral therapy. J Int AIDS Soc. 2016 Jan 29;19(1):20631.

doi: 10.7448/IAS.19.1.20631. PMID: 26829360; PMCID: PMC4733944.

 

16.Huang YS, Chan CK, Tsai MS, Lee KY, Lin SW, Chang SY, Hung CC, Chang SC.

Kidney dysfunction associated with tenofovir exposure in human immunodeficiency

virus-1-infected Taiwanese patients. J Microbiol Immunol Infect. 2017

Oct;50(5):595-603. doi: 10.1016/j.jmii.2015.08.019. Epub 2015 Sep 9. PMID:

26514942.

 

17.Chang EK, Kao KL, Tsai MS, Yang CJ, Huang YT, Liu CY, Liao CH. Occult

Klebsiella pneumoniae bacteremia at emergency department: A single center

experience. J Microbiol Immunol Infect. 2015 Dec;48(6):684-91. doi:

10.1016/j.jmii.2015.08.010. Epub 2015 Sep 9. PMID: 26510516.

 

18.Lo YC, Tsai MS, Sun HY, Hung CC, Chuang JH. National Trend and

Characteristics of Acute Hepatitis C among HIV-Infected Individuals: A Matched

Case-Control Study-Taiwan, 2001-2014. PLoS One. 2015 Oct 6;10(10):e0139687. doi:

10.1371/journal.pone.0139687. PMID: 26439381; PMCID: PMC4595084.

 

19.Lin KY, Liao SH, Liu WC, Cheng A, Lin SW, Chang SY, Tsai MS, Kuo CH, Wu MR,

Wang HP, Hung CC, Chang SC. Cholelithiasis and Nephrolithiasis in HIV-Positive

Patients in the Era of Combination Antiretroviral Therapy. PLoS One. 2015 Sep

11;10(9):e0137660. doi: 10.1371/journal.pone.0137660. PMID: 26360703; PMCID:

PMC4567270.

 

20.Yang CJ, Chen YH, Tsai MS, Hung CC. Optimal dose of benzathine penicillin G

for the treatment of early syphilis in HIV-infected patients in the era of

combination antiretroviral therapy. Clin Infect Dis. 2015 May 1;60(9):1443-4.

doi: 10.1093/cid/civ029. Epub 2015 Jan 26. PMID: 25628383.

 

21.Lee KY, Tsai MS, Kuo KC, Tsai JC, Sun HY, Cheng AC, Chang SY, Lee CH, Hung

CC. Pneumococcal vaccination among HIV-infected adult patients in the era of

combination antiretroviral therapy. Hum Vaccin Immunother. 2014;10(12):3700-10.

doi: 10.4161/hv.32247. PMID: 25483681; PMCID: PMC4514044.

 

22.Sun HY, Sheng WH, Tsai MS, Lee KY, Chang SY, Hung CC. Hepatitis B virus

coinfection in human immunodeficiency virus-infected patients: a review. World J

Gastroenterol. 2014 Oct 28;20(40):14598-614. doi: 10.3748/wjg.v20.i40.14598.

PMID: 25356024; PMCID: PMC4209527.

 

23.Tseng YT, Yang CJ, Chang SY, Lin SW, Tsai MS, Liu WC, Wu PY, Su YC, Luo YZ,

Yang SP, Hung CC, Chang SC. Incidence and risk factors of skin rashes and

hepatotoxicity in HIV-infected patients receiving nevirapine-containing

combination antiretroviral therapy in Taiwan. Int J Infect Dis. 2014

Dec;29:12-7. doi: 10.1016/j.ijid.2014.08.012. Epub 2014 Oct 12. PMID: 25312984.

 

24.Yang JJ, Huang CH, Liu CE, Tang HJ, Yang CJ, Lee YC, Lee KY, Tsai MS, Lin

SW, Chen YH, Lu PL, Hung CC. Multicenter study of trimethoprim/sulfamethoxazole-

related hepatotoxicity: incidence and associated factors among HIV-infected

patients treated for Pneumocystis jirovecii pneumonia. PLoS One. 2014 Sep

3;9(9):e106141. doi: 10.1371/journal.pone.0106141. PMID: 25184238; PMCID:

PMC4153565.

 

25.Tsai MS, Yang CJ, Lee NY, Hsieh SM, Lin YH, Sun HY, Sheng WH, Lee KY, Yang

SP, Liu WC, Wu PY, Ko WC, Hung CC. Jarisch-Herxheimer reaction among HIV-

positive patients with early syphilis: azithromycin versus benzathine penicillin

G therapy. J Int AIDS Soc. 2014 Aug 28;17(1):18993. doi: 10.7448/IAS.17.1.18993.

PMID: 25174641; PMCID: PMC4150017.

 

26.Wu PY, Chen MY, Hsieh SM, Sun HY, Tsai MS, Lee KY, Liu WC, Yang SP, Luo YZ,

Zhang JY, Sheng WH, Hung CC. Comorbidities among the HIV-infected patients aged

40 years or older in Taiwan. PLoS One. 2014 Aug 13;9(8):e104945. doi:

10.1371/journal.pone.0104945. PMID: 25119532; PMCID: PMC4132082.

 

27.Lin KY, Cheng CY, Yang CJ, Tsai MS, Hsieh SM, Sun HY, Sheng WH, Chen MY,

Chang SY, Cheng SH, Hung CC. Skin rash related to once-daily boosted darunavir-

containing antiretroviral therapy in HIV-infected Taiwanese: incidence and

associated factor. J Infect Chemother. 2014 Aug;20(8):465-70. doi:

10.1016/j.jiac.2014.04.006. Epub 2014 May 20. PMID: 24855915.

 

28.Hung CC, Wu SM, Lin PH, Sheng WH, Yang ZY, Sun HY, Tsai MS, Lee KY, Huang

MS, Chang SF, Su YC, Liu WC, Chang SY. Increasing incidence of recent hepatitis

D virus infection in HIV-infected patients in an area hyperendemic for hepatitis

B virus infection. Clin Infect Dis. 2014 Jun;58(11):1625-33. doi:

10.1093/cid/ciu127. Epub 2014 Mar 5. PMID: 24599769; PMCID: PMC4072904.

 

29.Sun HY, Cheng CY, Lee NY, Yang CJ, Liang SH, Tsai MS, Ko WC, Liu WC, Wu PY,

Wu CH, Lin HH, Hung CC. Seroprevalence of hepatitis B virus among adults at high

risk for HIV transmission two decades after implementation of nationwide

hepatitis B virus vaccination program in Taiwan. PLoS One. 2014 Feb

26;9(2):e90194. doi: 10.1371/journal.pone.0090194. PMID: 24587275; PMCID:

PMC3935970.

 

30.Lee KY, Lin SW, Sun HY, Kuo CH, Tsai MS, Wu BR, Tang SY, Liu WC, Chang SY,

Hung CC. Therapeutic drug monitoring and pharmacogenetic study of HIV-infected

ethnic Chinese receiving efavirenz-containing antiretroviral therapy with or

without rifampicin-based anti-tuberculous therapy. PLoS One. 2014 Feb

14;9(2):e88497. doi: 10.1371/journal.pone.0088497. PMID: 24551111; PMCID:

PMC3925114.

 

31.Chang YH, Liu WC, Chang SY, Wu BR, Wu PY, Tsai MS, Hung CC, Lew-Ting CY.

Associated factors with syphilis among human immunodeficiency virus-infected men

who have sex with men in Taiwan in the era of combination antiretroviral

therapy. J Microbiol Immunol Infect. 2014 Dec;47(6):533-41. doi:

10.1016/j.jmii.2013.11.003. Epub 2013 Dec 31. PMID: 24388575.

 

32.Lin PH, Lai CC, Yang JL, Huang HL, Huang MS, Tsai MS, Yang CJ, Cheng CL, Su

YC, Chang SF, Liu WC, Hung CC, Chang SY, Chang SC. Slow immunological

progression in HIV-1 CRF07_BC-infected injecting drug users. Emerg Microbes

Infect. 2013 Dec;2(12):e83. doi: 10.1038/emi.2013.83. Epub 2013 Dec 11. PMID:

26038447; PMCID: PMC3880871.

 

33.Yang JJ, Tsai MS Sun HY, Hsieh SM, Chen MY, Sheng WH, Chang SC. Autoimmune

diseases-related arthritis in HIV-infected patients in the era of highly active

antiretroviral therapy. J Microbiol Immunol Infect. 2015 Apr;48(2):130-6. doi:

10.1016/j.jmii.2013.08.002. Epub 2013 Sep 21. PMID: 24064287.

 

34.Sheng WH, Chuang YC, Sun HY, Tsai MS, Chang SY, Hung CC, Chang SC.

Prophylactic effect of lamivudine-based antiretroviral therapy on incident

hepatitis B virus infection among HIV-infected patients. Clin Infect Dis. 2013

Nov;57(10):1504-6. doi: 10.1093/cid/cit511. Epub 2013 Aug 6. PMID: 23926178.

 

35.Tsai MS, Chang SY, Lo YC, Yang CJ, Sun HY, Liu WC, Wu PY, Hung CC. Hepatitis

B virus (HBV) coinfection accelerates immunologic progression in patients with

primary HIV infection in an area of hyperendemicity for HBV infection. J Infect

Dis. 2013 Oct 1;208(7):1184-6. doi: 10.1093/infdis/jit299. Epub 2013 Jul 9.

PMID: 23840045.

 

36.Chou YJ, Lee KY, Tsai MS, Sun HY, Hung CC. Use of cephalexin plus

trimethoprim/sulfamethoxazole vs cephalexin alone for treatment of uncomplicated

cellulitis. Clin Infect Dis. 2013 Oct;57(8):1216-7. doi: 10.1093/cid/cit449.

Epub 2013 Jul 2. PMID: 23821731.

 

37.Tsai MS, Hung CC, Liu WC, Chen KL, Chen MY, Hsieh SM, Sheng WH, Sun HY, Shih

TT. Reduced bone mineral density among HIV-infected patients in Taiwan:

prevalence and associated factors. J Microbiol Immunol Infect. 2014

Apr;47(2):109-15. doi: 10.1016/j.jmii.2012.08.026. Epub 2012 Oct 13. PMID:

23073318.

 

38.Lee KY, Ho CC, Ji DD, Lee CM, Tsai MS, Cheng AC, Chen PY, Tsai SY, Tseng YT,

Sun HY, Lee YC, Hung CC, Chang SC. Etiology of pulmonary complications of human

immunodeficiency virus-1-infected patients in Taiwan in the era of combination

antiretroviral therapy: a prospective observational study. J Microbiol Immunol

Infect. 2013 Dec;46(6):433-40. doi: 10.1016/j.jmii.2012.08.003. Epub 2012 Sep

29. PMID: 23026388.

 

（更新日期：2020年12月23日）